USP revising standards on sterile products compounding

Article

USP is putting into place changes in compounding standards following reports of patients hurt by pharmacist-compounded drugs

Related Content
Leqvio Gets Label Update For Earlier Use in Patients with Heart Disease

Leqvio Gets Label Update For Earlier Use in Patients with Heart Disease

July 12th 2023
Article

Recent safety data also allowed four adverse events to be removed from the label.

Using Artificial Intelligence, Machine Learning to Aid in Skin Cancer Diagnoses

Using Artificial Intelligence, Machine Learning to Aid in Skin Cancer Diagnoses

July 5th 2023
Article

How does AI help reduce the burden on specialist dermatology services and help simplify the screening process?

Pharmacist-Directed Weight Loss Service Can Help Patients in Ambulatory Care Clinics

Pharmacist-Directed Weight Loss Service Can Help Patients in Ambulatory Care Clinics

June 27th 2023
Article

The most frequently prescribed weight loss medication was semaglutide (Ozempic), followed by liraglutide (Saxenda), and dulaglutide (Trulicity).

Opioid Use Disorder Treatment Inconsistent Around United States

Opioid Use Disorder Treatment Inconsistent Around United States

June 26th 2023
Article

At the state level, medication treatment rates ranged from 17.7% in Kansas to 82.8% in Maine.

Over Half of At-Home Ketamine Users Misuse the Treatment

Over Half of At-Home Ketamine Users Misuse the Treatment

June 26th 2023
Article

A new report recommended that ketamine therapy be used only in combination with psychotherapy under the supervision of a clinician.

Contraceptives, Gender-Affirming Care, and Other Hot Topics for Pharmacists

Contraceptives, Gender-Affirming Care, and Other Hot Topics for Pharmacists

June 13th 2023
Article

What is the state of OTC contraception, what’s next for IUDs, and why are so many transgender people denied care?

© 2024 MJH Life Sciences

All rights reserved.